Tandem Diabetes Care (TNDM) stock
TNDM's Quality Score was unchanged on Mon, Oct 5, at -3.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Why TNDM lags the market
Tandem Diabetes Care returned -86% over five years to the S&P 500's +91%; its operating margin went from -1.6% to -18.5%.
Diluted EPS went from -$0.56 in fiscal 2020 to -$3.04 in fiscal 2025.
2 more drivers, the timeline, and the peer table, for Pro members
Why TNDM scores -3
PoorTrending down, 0 of 14 checks firingWhat the Quality Score means
- −2Long-term trend below a falling 200-day average, down over two years
- +1Growth sales up 4% on the year, gross margin up 3.5 points
- Volatility subtracts
- Cash flow subtracts
What's next
Reports Thu Nov 5, after the close
After its last 4 reports it closed +14.4% on average, higher 3 of 4 times.
What would turn TNDM's score around: 8 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Nothing is firing on TNDM right now
One per group is shown here.
Also on the chart
- RSI 1440.4
- MACD (12, 26, 9)Above signal
- 50-day average$19.51
- 200-day average$19.41
- ADX 1423.7
- Support$14.83
- Resistance$18.03
- Bollinger Bands (20, 2)Inside
- Volume0.8x
How TNDM ranks in Medical Devices
TNDM is #78 of 84 by Quality Score. The top three are shown with their scores, and more by name.
BLFS10/1422
CBLL10/1418
HTFL9/1417
TFXOpen for its score
TMDXOpen for its score
UFPTOpen for its score
WRBYOpen for its score
TNDM0/14-3
When does TNDM report earnings, and what happens after?
Reports Thu Nov 5, after the close (in 30 days). The company has set the date.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 6, 2026After close | After close | -7.5% | +19.1% | +23.1% |
| May 7, 2026After close | After close | +8.3% | -16.2% | -23.4% |
| Feb 19, 2026After close | After close | +22.8% | +32.7% | +39.3% |
| Nov 6, 2025After close | After close | +20.0% | +22.0% | +31.5% |
Who is trading TNDM
TNDM trades by Congress and the White House
2 trades disclosed in the last six months. The newest:
About Tandem Diabetes Care
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of TNDM's score, with the points and the reason
- All 14 checks on TNDM and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on TNDM
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.